1. Home
  2. UNCY vs FUSB Comparison

UNCY vs FUSB Comparison

Compare UNCY & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • FUSB
  • Stock Information
  • Founded
  • UNCY 2016
  • FUSB 1952
  • Country
  • UNCY United States
  • FUSB United States
  • Employees
  • UNCY N/A
  • FUSB N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • FUSB Major Banks
  • Sector
  • UNCY Health Care
  • FUSB Finance
  • Exchange
  • UNCY Nasdaq
  • FUSB Nasdaq
  • Market Cap
  • UNCY 74.2M
  • FUSB 69.5M
  • IPO Year
  • UNCY 2021
  • FUSB N/A
  • Fundamental
  • Price
  • UNCY $4.93
  • FUSB $12.26
  • Analyst Decision
  • UNCY Strong Buy
  • FUSB
  • Analyst Count
  • UNCY 5
  • FUSB 0
  • Target Price
  • UNCY $55.20
  • FUSB N/A
  • AVG Volume (30 Days)
  • UNCY 419.1K
  • FUSB 3.6K
  • Earning Date
  • UNCY 11-12-2025
  • FUSB 10-28-2025
  • Dividend Yield
  • UNCY N/A
  • FUSB 2.25%
  • EPS Growth
  • UNCY N/A
  • FUSB N/A
  • EPS
  • UNCY N/A
  • FUSB 0.97
  • Revenue
  • UNCY N/A
  • FUSB $36,046,000.00
  • Revenue This Year
  • UNCY N/A
  • FUSB N/A
  • Revenue Next Year
  • UNCY $19,912.34
  • FUSB N/A
  • P/E Ratio
  • UNCY N/A
  • FUSB $12.72
  • Revenue Growth
  • UNCY N/A
  • FUSB N/A
  • 52 Week Low
  • UNCY $3.71
  • FUSB $10.30
  • 52 Week High
  • UNCY $11.00
  • FUSB $14.30
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 66.90
  • FUSB 49.77
  • Support Level
  • UNCY $4.33
  • FUSB $12.15
  • Resistance Level
  • UNCY $4.81
  • FUSB $12.45
  • Average True Range (ATR)
  • UNCY 0.31
  • FUSB 0.14
  • MACD
  • UNCY 0.04
  • FUSB 0.01
  • Stochastic Oscillator
  • UNCY 70.07
  • FUSB 57.78

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About FUSB First US Bancshares Inc.

First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.

Share on Social Networks: